Table 3. Transmission disequilibrium test and genotype frequency of TLR5 stop codon in SLE clinical subgroups.
SLE characteristic | T/NT for 1174C | T, % | P value | 1174CC, n | 1174CT; n (%) | P value | |
---|---|---|---|---|---|---|---|
Renal | + | 9:2 | 81.8 | 0.035 | 72 | 4 (5.3) | 0.76 |
– | 8:4 | 66.7 | 0.25 | 96 | 7 (6.8) | ||
Arthritis | + | 13:5 | 72.2 | 0.059 | 147 | 11 (7.0) | 0.61 |
– | 4:1 | 80.0 | 0.17 | 19 | 0 (0) | ||
Hematologic | + | 10:5 | 66.7 | 0.20 | 83 | 8 (8.8) | 0.22 |
– | 6:1 | 85.7 | 0.047 | 77 | 3 (3.8) | ||
α-CL Ab | + | 8:2 | 80.0 | 0.058 | 54 | 4 (6.9) | 1.00 |
– | 6:3 | 66.7 | 0.31 | 66 | 6 (8.3) | ||
α-dsDNA Ab | + | 9:6 | 60.0 | 0.44 | 97 | 9 (8.5) | 0.21 |
– | 8:0 | 100.0 | 0.00087 | 61 | 2 (3.2) | ||
α-Sm Ab | + | 2:2 | 50.0 | 1 | 19 | 2 (9.5) | 0.67 |
– | 14:4 | 77.8 | 0.019 | 110 | 9 (7.6) |
Transmission (T) rates and genotype frequency of TLR5 SNP C1174T were evaluated in 199 SLE patients with different available clinical features. Rates indicate transmission of 1174C (wild-type allele). For the genotype frequency analysis, only SLE patients who had the indicated clinical data available were included. α-CL, anticardiolipin; Sm, Smith antigen.